Scroll Top
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Clinical Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Events and Team Interviews
Parkinson 101
Technical Articles
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Clinical Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Events and Team Interviews
Parkinson 101
Technical Articles
Home
»
First Parkinson’s patient dosed in GT-02287 clinical trial - Perspectives from Gain Therapeutics
Related Posts
Menu
Close
About us
Overview
Leadership Team
Board of Directors
Clinical Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Events and Team Interviews
Parkinson 101
Technical Articles
Related Posts
First Parkinson’s patient dosed in GT-02287 clinical trial
Parkinson’s News Today
March 19, 2025
First Parkinson’s patient dosed in GT-02287 clinical trial
Related Posts
Post navigation
Previous Post
Gain Therapeutics Doses First Patient in Phase 1b Parkinson’s Trial
Next Post
Webinar: The opportunities in neuroscience drug discovery
Latest Articles
Clear Filters
January 26, 2026
5 Investigational Therapies That Could Change the Parkinson’s Landscape
https://www.biospace.com/drug-development/5-investigational-therapies-that-could-change-the-parkinsons-landscape
Read More
January 13, 2026
Early trial data suggest GT-02287 may aid Parkinson’s symptoms
https://parkinsonsnewstoday.com/news/early-trial-data-suggest-gt-02287-aid-parkinsons-symptoms/
Read More
January 9, 2026
New data suggest enzyme modulator may slow Parkinson’s
https://longevity.technology/news/new-data-suggest-enzyme-modulator-may-slow-parkinsons/
Read More
Close
About us
Overview
Leadership Team
Board of Directors
Clinical Advisory Board
Partners
Careers
Science and Technology
Platform Technology
Science
Posters
Publications
Pipeline
Investors & Media
Overview
News & Events
Stock Information
Analyst Coverage
Investor Resources
SEC Filings
Governance Documents
Contact Us
Perspectives
Events and Team Interviews
Parkinson 101
Technical Articles